Health Trials

Neuroendocrine Carcinoma of Prostate

2

Review clinical trials related to Neuroendocrine Carcinoma of Prostate. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

The purpose of this study is to find out whether 177Lu-DTPA-SC16.56 is a safe treatment for people with small-cell lung cancer or neuroendocrine prostate cancer

Participants needed: 12
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Apr 14, 2026Locations: 7
Eligibility criteria

Subjects with histologically proven progressive metastatic high-grade neuroendoc... [+8]

History of anaphylactic reaction to humanized or human antibodies [+17]

Read more
Status: Recruiting

Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients

This is a phase 2 single-arm, open-label clinical trial designed to evaluate the efficacy and safety of tarlatamab in patients with relapsed extrapulmonary neuroendocrine carcinoma (EPNEC) who have previously received platinum-based first-line chemotherapy. Participants will receive tarlatamab on Cycle 1 Day 1 (C1D1), Day 8 (C1D8), and Day 15 (C1D15), followed by administration every two weeks thereafter. No placebo control is included in this study.

Participants needed: 60
Trial details
Phase: Phase 2Age: 19+Biological sex: AllType: InterventionalSponsor: Inkeun ParkUpdated: Apr 13, 2026Locations: 4
Eligibility criteria

Age ≥19 years at the time of signing the informed consent. [+10]

Subject is asymptomatic from brain metastases [+41]

Read more